An open multicenter phase II trial of weekly docetaxel for advanced-stage non-small-cell lung cancer in elderly patients with significant comorbidity and/or poor performance status: the GFPC 02-02b study

[pdf]Le Caer Lung Cancer 2007_57-1_72[/pdf]